Search results
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks· 6 days agoFree Report) boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor Keytruda approved for several types of cancer and alone accounting for more than ...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 2 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting
Digital Journal· 4 days agoIndividualized neoantigen therapies are designed to train and activate an antitumor immune response by generating specific T-cell responses based on the unique mutational signature of a patient's ...
Is Merck & Co., Inc. (NYSE:MRK) the Best Dow Stock To Buy According to Hedge Funds?
Insider Monkey via Yahoo Finance· 13 hours agoWe recently identified the best dow stocks according to hedge funds. Even though Merck & Co., Inc....
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 3 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
ASCO 2024: Merus touts positive Phase II data for head and neck cancer antibody
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe Phase II study is evaluating petosemtamab in combination with Merck & Co’s PD-1 inhibitor ...
Iovance (IOVA) Up 5% on Updated Data From Melanoma Study
Zacks via Yahoo Finance· 2 days agoIovance (IOVA) shares updated data from a mid-stage study, which showed that treatment with its...
Why This Top 4% Biotech Just Catapulted To A Record High
Investor's Business Daily· 1 day agoThe Netherlands-based biotech paired its drug, petosemtamab, with Merck's (MRK) cancer blockbuster, ...
Why Merck (MRK) is a Top Momentum Stock for the Long-Term
Zacks via Yahoo Finance· 4 days agoMerck (MRK) Based in Kenilworth, NJ, Merck & Co. boasts more than six blockbuster products in its...
Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?
Benzinga via Yahoo Finance· 2 days agoKeytruda (pembrolizumab) is Merck & Co Inc’s (NYSE:MRK) top selling cancer drug. The abstract...